Gerald Maxwell Cherf

Max Cherf currently serves as the Director at Tentarix Biotherapeutics, a position held since April 2024. Prior to this role, Max was at Enlaza Therapeutics from April 2022 to March 2024, advancing from Principal Scientist and Group Leader to Senior Scientist and Project Team Lead. Max’s experience also includes a tenure at Denali Therapeutics from March 2018 to April 2022 as a Senior Scientist and Technical Team Lead, and earlier as a Scientist. The academic background includes a Doctor of Philosophy (PhD) in Bioengineering from Stanford University and a Bachelor of Science (BS) in Biomolecular Engineering from the University of California, Santa Cruz, where Max also held positions ranging from Research Assistant to Assistant Specialist.